Research Advances and Clinical Impact of New Data From Crohn’s & Colitis Congress® 2019 *

February 7-9, 2019; Las Vegas, Nevada
Review expert commentary of key data from the 2019 Crohn’s and Colitis Congress

Share

Program Content

Activities

Monitoring in IBD
Disease and Drug Monitoring in IBD: My Take on Data From Crohn’s & Colitis Congress 2019
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2019

Expires: June 05, 2020

New and Emerging Therapy
New and Emerging IBD Treatments: Our Take on Data From Crohn’s & Colitis Congress 2019
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: June 26, 2019

Expires: June 24, 2020

Faculty

cover img faculity

Baldeep S. Pabla, MD, MSCI

Gastroenterology Fellow
Department of Internal Medicine; Division of Gastroenterology, Hepatology, and Nutrition
Vanderbilt University Medical Center
Nashville, Tennessee

cover img faculity

David A. Schwartz, MD, FACG, AGAF

Professor of Medicine
Department of Gastroenterology
Director, IBD Center
Vanderbilt University
Nashville, Tennessee

Supporters

Supported by educational grants from

Celgene without Corporation

Takeda Pharm USA

Partners

AGA CCF

ProCE Banner

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.